VFLO: An ETF With Attractive Valuation, An Option For Diversification

The VictoryShares Free Cash Flow ETF (VFLO) offers a distinct value investment approach by weighting holdings based on free cash flow, resulting in significant exposure to the healthcare and energy sectors. Trading at a notable valuation discount with a P/E of 12.5x compared to the Russell 1000, VFLO has outperformed most value peers in 2024, though it lags broader market indexes and exhibits higher volatility. While not a traditional defensive play, VFLO is presented as a compelling option for value-oriented investors seeking sector diversification and potential outperformance.

Analysis

The VictoryShares Free Cash Flow ETF (VFLO) presents a differentiated approach to value investing by utilizing a free cash flow-weighted methodology, which results in a deep value tilt and significant portfolio concentration in the healthcare and energy sectors. Its valuation is compelling, with a price-to-earnings ratio of 12.5x representing a steep discount to the Russell 1000, yet the fund maintains comparable growth rates in its key sectors. While VFLO has outperformed most of its value peers in 2024, it has simultaneously lagged broader market indexes. Critically, the fund exhibits higher volatility and does not possess the defensive characteristics typically associated with traditional value strategies, positioning it as a specialized, rather than a core defensive, holding.

Key Decisions for Investors

• Value-focused investors should consider VFLO for its unique free-cash-flow screening and deep value characteristics, which can serve as a diversifying satellite holding away from conventional value funds.
• Investors must be aware that VFLO's higher volatility and lack of a traditional defensive profile make it less suitable for portfolios prioritizing capital preservation or low-risk equity exposure.
• Given the fund's heavy concentration, it is crucial to assess existing portfolio allocations to the healthcare and energy sectors to manage potential overexposure risk.
• Expect potential underperformance relative to broad market benchmarks, as the fund's strategy is tailored to a specific value factor that may lag in growth-driven market cycles.